Mother’s Day Classic Melbourne

Description

Organiser: Mother’s Day Classic

WALK & RUN 8km/4km

RUN 8km/12km

Entertainment and Kids Zone

The main stage will feature The Listies, a multi-award-winning comedy duo known for their hilarious, family-friendly performances that keep kids and parents laughing. Enjoy the infectious energy of ARIA-nominated Whistle & Trick, the soulful pop and disco-funk vibes of Athanasia, and the dynamic musical talents of Sam + Sam.

Around the village, delight in Circus Tricks, Bouncy Beasts, Shaggy Rovers, and Stilt Walkers, plus family favourites like Face Painting, Bubble Play, the CBUS Cardboard City and much more! Keep an ear out for The Pit Crew and Hot Socks Big Band, bringing vibrant live music on course.

A day of comedy, music, and family fun awaits!Entertainment and Kids Zone

About

Over the past 27 years, the Mother's Day Classic community has donated $47.3 million to fund life-saving breast cancer research and ovarian cancer research.

Thanks to research, the five-year survival rate for breast cancer has increased from 84 per cent to 92 per cent since the Mother’s Day Classic started in 1998. There’s still more to be done to achieve the goal of zero deaths from breast cancer.

Tragically, treatment, early detection, and preventative medical research advances for ovarian cancer have been limited. Treatment options and targeted therapies have only marginally improved in 30 years and there is currently no readily available, non-invasive early detection test for ovarian cancer. The average five year survival rate for a woman diagnosed with ovarian cancer is just 49 per cent. Over the past 27 years, the Mother's Day Classic community has donated $47.3 million to fund life-saving breast cancer research and ovarian cancer research.

Thanks to research, the five-year survival rate for breast cancer has increased from 84 per cent to 92 per cent since the Mother’s Day Classic started in 1998. There’s still more to be done to achieve the goal of zero deaths from breast cancer.

Tragically, treatment, early detection, and preventative medical research advances for ovarian cancer have been limited. Treatment options and targeted therapies have only marginally improved in 30 years and there is currently no readily available, non-invasive early detection test for ovarian cancer. The average five year survival rate for a woman diagnosed with ovarian cancer is just 49 per cent.